Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

  • Codony, Sandra|||0000-0003-0539-673X
  • Pont, Caterina|||0000-0001-9118-0892
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Di Pede-Mattatelli, Ania
  • Calvó-Tusell, Carla|||0000-0003-2681-8460
  • Feixas, Ferran|||0000-0001-5147-0000
  • Osuna, Sílvia|||0000-0003-3657-6469
  • Jarné-Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela|||0000-0002-2890-3856
  • Loza, María Isabel|||0000-0003-4730-0863
  • Brea, José|||0000-0002-5523-1979
  • Pérez, Belén|||0000-0001-5801-1704
  • Bartra, Clara
  • Sanfeliu i Pujol, Coral|||0000-0002-9004-1206
  • Juárez-Jiménez, Jordi|||0000-0003-1464-1397
  • Morisseau, Christophe
  • Hammock, Bruce D.|||0000-0003-1408-8317
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Vázquez, Santiago|||0000-0002-9296-6026
  • Muñoz-Torrero López-Ibarra, Diego|||0000-0002-8140-8555
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

  • Codony, Sandra
  • Pont, Caterina
  • Griñán-Ferré, Christian
  • Di Pede-Mattatelli, Ania
  • Calvó-Tusell, Carla
  • Feixas, Ferran
  • Osuna, Sílvia
  • Jarné-Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela
  • Loza, María Isabel
  • Brea, José Manuel
  • Pérez, Belén
  • Bartra Cabré, Clara
  • Sanfeliu, Coral
  • Juárez-Jiménez, Jordi
  • Morisseau, Christophe
  • Hammock, Bruce D.
  • Pallàs, Mercè
  • Vázquez, Santiago
  • Muñoz-Torrero, Diego
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration., This work was supported by grants PID2020-118127RB-I00, SAF2017-82771-R, PID2020-115683GA-I00, PGC2018- 102192-B-I00, PID2019-106285RB, and RTI2018-101032-JI00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, ED431C 2018/21 and ED431G 2019/02 from Xunta de Galicia, and 2017SGR106, 2017SGR1707, and 2019LLAV00017 from AGAUR. Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIH-NIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616 to B.D.H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Fellowships from Ministerio de Educación, Cultura y Deporte to C.P. (FPU15/01131), from the University of Barcelona to S.C., and a starting grant from the European Research Council (ERC-2015-StG-679001- NetMoDEzyme) to S.O. are gratefully acknowledged. We thank Ms. Cecilia Mariani for technical assistance in the assays with mAChE., Peer reviewed